Triple-negative breast cancer (TNBC), which lacks estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), is a highly aggressive subtype of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.